(Q34287016)

1 August 2017

1 reference

title

Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease (English)

1 reference

1 August 2017

0 references

0 references

1

Mark H Tuszynski

1 reference

1 August 2017

Armin Blesch

2

1 reference

1 August 2017

publication date

1 January 2004

1 reference

1 August 2017

number of pages

9

1 reference

Progress in Brain Research

inferred from page(s)

published in

1 reference

1 August 2017

volume

146

1 reference

1 August 2017

page(s)

441-449

1 reference

The cholinergic hypothesis of geriatric memory dysfunction

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Bcl-xL protects adult septal cholinergic neurons from axotomized cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Sympathetic sprouting in the central nervous system: a model for studies of axonal growth in the mature mammalian brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Central cholinergic systems and cognition

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Inducible gene expression systems for higher eukaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Neurturin, a relative of glial-cell-line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Brain-Derived Neurotrophic Factor Protects Dopaminergic Cells from 6-Hydroxydopamine Toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

High level transactivation by a modified Bombyx ecdysone receptor in mammalian cells without exogenous retinoid X receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Spontaneous and augmented growth of axons in the primate spinal cord: effects of local injury and nerve growth factor-secreting cell grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Basal forebrain lesions in monkeys disrupt attention but not learning and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Hypophagia is induced by intracerebroventricular administration of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946028-7

7 January 2021

10.1016/S0079-6123(03)46028-7

Identifiers

DOI

1 reference

1 August 2017

1 reference